Salomon M Stemmer

4PUBLICATIONS
80CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 14, 2026
PDE5a Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking Through a Non-canonical cGMP-Dependent Pathway.

|May 18, 2026
Lipid Nanoparticle-Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors.

|Apr 07, 2026
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Feb 13, 2023
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects.

Pnina Fishman, Salomon M Stemmer, Avital Bareket-Samish

Pageof 1

Frequent Collaborators

1 joint publications

Pnina Fishman

1 joint publications

Avital Bareket-Samish

1 joint publications

Elena Garralda

1 joint publications

Christoph Markert